Sign in

NCT01571700Enrolling by invitation

Investigation of Dysynchrony in Patients With Pulmonary Hypertension

Source: ClinicalTrials.gov · Last updated 19 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of the study is to determine whether patients with pulmonary hypertension (PH) have dysynchrony, and if so whether it is electrical or mechanical. Once this has been determined, during a catheterization the investigators will test if pacing the heart improves blood circulation.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
100 (estimated)
First submitted
3 Apr 2012
Start date
Sept 2006
Primary completion date
Dec 2029
Lead sponsor
Stanford University
NCT number
NCT01571700

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From Sept 2006 to the primary completion date, Dec 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Reversible cause of pulmonary hypertension

Age

  • Age \< 5 yrs (for phase 2)

Who the study is looking for

  • Pulmonary artery mean pressure at rest of 25 mm Hg
  • Controls (for phase 2) Patients undergoing transcatheter closure of secundum ASD Patients undergoing echocardiogram and ECG as part of work-up for functional murmur who have normal intracardiac anatomy

Age in the registry: 5 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Stanford Hospital
Coordinator of this site? Confirm its status		StanfordUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.